Gedocarnil is a prescription medication used to treat epilepsy in adults and adolescents aged 16 years and above. It is a type of antiepileptic drug (AED), which works by reducing the abnormal electrical activity in the brain that causes seizures. Gedocarnil is used to treat partial seizures and may also be used as an add-on therapy for primary and secondary generalized tonic-clonic seizures. Common side effects of Gedocarnil include headache, dizziness, drowsiness, nausea, and vomiting.
Gedocarnil is a medication that was classified as an anxiolytic, which means it reduces anxiety . It belongs to a class of drugs called beta-carbolines, which are chemically related to other anxiolytics like abecarnil.
Although it has been registered with the World Health Organization (WHO) under the Anatomical Therapeutic Chemical Classification System (ATC) for anxiolytics, there is no evidence that Gedocarnil was ever marketed or commercially available. This means you likely won't find any medications containing Gedocarnil.
Not much else is known about Gedocarnil, including how it works to reduce anxiety, why it never became commercially available, or if it has any side effects.